News
ReNeuron's latest press releases
ReNeuron to present at 2006 BioSquare conference. 07/03/06
Guildford, UK, 7 March 2006: ReNeuron Group plc (LSE: RENE.L) today announces that it will participate in the 2006 BioSquare conference at the …
Read articleReNeuron announces initial pre-clinical data with its ReN004 human stem cell lines for Parkinson's disease. 16/02/06
Guildford, UK, 16 February 2006: ReNeuron Group plc (LSE: RENE) today announces that initial in vivo testing of its ReN004 candidate stem cell lines …
ReNeuron signs manufacturing contract with Angel Biotechnology for its ReN005 stem cell line for Huntington's disease. 07/02/06
Guildford, UK, 7 February 2006: ReNeuron Group plc (LSE: RENE.L) today announced that it has signed a manufacturing contract with Angel Biotechnology …
ReNeuron announces further positive pre-clinical efficacy data with ReN001 stem cell therapy for stroke. 06/02/06
Guildford, UK, 24 January 2006: ReNeuron Group plc (LSE: RENE.L) today announces that it has generated further positive pre-clinical efficacy data …
ReNeuron receives Notice of Allowance from US Patent Office for neural stem cell transplantation patent application. 24/01/06
ReNeuron Group plc (LSE: RENE.L) today announced that it has received a Notice of Allowance from the US Patent and Trademark Office concerning a key …
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page